Raymond Dingledine
Raymond Dingledine is a prominent American neuroscientist known for his significant contributions to the field of neuroscience, particularly in the study of epilepsy and neuropharmacology. He is a professor at the Emory University School of Medicine and has published extensively on the mechanisms of seizures and the development of antiepileptic drugs.
Early Life and Education[edit | edit source]
Raymond Dingledine was born in the United States. He completed his undergraduate studies in biology at the University of California, Berkeley. He then pursued a Ph.D. in pharmacology at the University of Iowa.
Career[edit | edit source]
Dingledine began his academic career as a postdoctoral fellow at the National Institutes of Health (NIH). He later joined the faculty at the University of North Carolina at Chapel Hill before moving to Emory University.
At Emory, Dingledine has held several key positions, including Chair of the Department of Pharmacology. His research has focused on understanding the cellular and molecular mechanisms underlying epilepsy and the development of new therapeutic strategies.
Research Contributions[edit | edit source]
Dingledine's research has significantly advanced the understanding of glutamate receptors and their role in neurodegenerative diseases. His work on the AMPA receptor has provided insights into how these receptors contribute to synaptic plasticity and excitotoxicity.
He has also been involved in the development of novel antiepileptic drugs and has contributed to the understanding of the blood-brain barrier's role in epilepsy.
Awards and Honors[edit | edit source]
Raymond Dingledine has received numerous awards for his contributions to neuroscience, including the Epilepsy Research Award from the American Epilepsy Society and the Julius Axelrod Award from the Society for Neuroscience.
Personal Life[edit | edit source]
Dingledine is married and has two children. He is an avid supporter of science education and has been involved in various outreach programs to promote interest in neuroscience among young students.
Related Pages[edit | edit source]
- Neuroscience
- Epilepsy
- Neuropharmacology
- Emory University School of Medicine
- Glutamate receptor
- AMPA receptor
- Synaptic plasticity
- Excitotoxicity
- Blood-brain barrier
References[edit | edit source]
External Links[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
